PHGE - Rasio utang marang kapitalisasi buku biomx.com

BiomX Inc. (PHGE) holds the status of an innovator in the treatment of severe infections, sparking optimism among medical professionals. The ratio of total debt to balance sheet capital demonstrates current financial stability, with the indicator standing at 0.32. BiomX Inc. (PHGE) minimizes operational risks through CDMO manufacturing, while strategic alliances with research centers enable the creation of alternatives to traditional antibiotics.

PHGE (BiomX) riwayat Utang marang nilai buku saka 04.07.2022 nganti 11.09.2026

Rincian metrik lan analitis perusahaan biomx.com (PHGE)

- rega lan prakiraan konsensus rega:

Rega saham BiomX|PHGE - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar PHGE|PHGE - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham BiomX|PHGE - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku biomx.com|PHGE - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas BiomX Inc.|PHGE - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal BiomX|PHGE - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku PHGE

Ringkesan analitik perusahaan:PHGE - BiomX Ltd

BiomX Inc. is developing the unique BOLT platform to create custom bacteriophages that replace traditional antibiotics. Scaling such innovations requires a balance between equity and debt. This ratio compares total debt to the book value of assets, determining financial stability and the resource base. Low values eliminate default risk but may limit the pace of expansion. The history of leverage relative to capitalization clearly demonstrates this strategic dependency.

Pesaing BiomX Inc.